Filed by Filing Services Canada Inc. 403-717-3898






OMB APPROVAL

OMB Number:

 3235-0116

Expires:

July 31, 2008

Estimated average burden

hours per response................

6.20

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

Form 6-K

REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934

For the month of        December 1, 2005

 


Commission File Number

001-32654

 

ANORMED INC.

(Translation of registrant’s name into English)

#200 – 20353 64th Avenue, Langley, British Columbia  Canada  V2Y 1N5

(Address of principal executive office)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
Form 20-F  [   ]   Form 40-F  [X]

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1):  [   ]

Note: Regulation S-T Rule 101(b)(1) only permits the submission in paper of a Form 6-K if submitted solely to provide an attached annual report to security holders.

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7):  [   ]

Note: Regulation S-T Rule 101(b)(7) only permits the submission in paper of a Form 6-K if submitted to furnish a report or other document that the registrant foreign private issuer must furnish and make public under the laws of the jurisdiction in which the registrant is incorporated, domiciled or legally organized (the registrant’s “home country”), or under the rules of the home country exchange on which the registrant’s securities are traded, as long as the report or other document is not a press release, is not required to be and has not been distributed to the registrant’s security holders, and, if discussing a material event, has already been the subject of a Form 6-K submission or other Commission filing on EDGAR.

Indicate by check mark whether the registrant by furnishing the information contained in this Form is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934. Yes  [   ]   No   [X]

If “Yes” is marked, indicate below the file number assigned to the registrant in connection with Rule 12g3-2(b): 82-_______________.

 

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.


  

ANORMED INC.

   

(Registrant)

Date

December 16, 2005

 

By

/ s / W.J. Adams

    

(Signature)*

   

William J. (Bill) Adams, Chief Financial Officer

* Print the name and title under the signature of the signing officer.

  


SEC 1815 (09-05)

Persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.






Other Events

AnorMED Inc. is filing as Exhibit 99.1 (which is incorporated by reference herein) a discussion identifying important factors that could adversely affect (i) AnorMED’s business, financial condition, results of operations and future prospects and (ii) the market price of AnorMED’s common shares.  

AnorMED Inc. is also filing as Exhibit 99.2 (which is incorporated by reference herein) a description of certain material Canadian and United States federal income tax consequences of the acquisition, income tax purposes and the purchase, ownership and disposition of AnorMED common shares.


Exhibit
Number

Description

99.1

AnorMED Risk Factors

99.2

Certain Material Canadian and United States Federal Income Tax Considerations for U.S. Shareholders